Benedict Hirth

I was looking back at my photos today and saw a picture of our Q3 incentive, when we joined our German colleagues at Oktoberfest, reminding me of the great people I work with. At i-Pharm Consulting, we believe a unified culture drives long-term success. Here are some crazy important statistics to consider when creating your recruitment strategy. The costs of a poor culture fit are high - lower engagement, higher turnover, and diminished morale/productivity. A Columbia study found 88% of hiring failures stem from poor fit rather than lack of skills. Prioritizing culture fit is crucial, as SHRM research shows 46% of hires fail within 18 months when it's not a focus. As a recruiter, I know skills aren't everything. The right culture fit can make or break even the most talented hire. That's why I thoroughly evaluate how a candidate will integrate with my client's team dynamics and values before presenting them. When assessing candidates, I look at passion alignment, communication styles, behavioural traits, and check references to understand their fit at prior organizations. While technical expertise is essential, I support hiring those who can thrive within the established culture. A strong culture fit creates employees invested in the company's mission who collaborate effectively. Combined with the right skills, it leads to engaged, high-performing, and successful long-term hires. Gallup research found that companies with engaged workforces outperform their peers by 147% in earnings per share. Now that is something to consider! If cultural fit is something you have struggled with when hiring, reach out to me for a conversation on the below. I am always happy to discuss our strategy. Phone:  1 332-219-0879 or  44 02075510728 Email: [email protected]

27

11 Kommentare

The CTIS deadline is approaching - please reach out if you need any help with the EU-CTR transition. We have great experts available to support you ASAP with: - Identifying relevant studies, providing CTIS training - CTIS Data Migration & Validation - Study Submissions and Authorizations - Ongoing Monitoring and Adjustments The EMA's new Clinical Trials Information System (CTIS) marks a significant milestone in managing clinical trials within the EU. With the January 31, 2025 deadline, the three-year transition period is ending, and the urgency for adaptation is becoming evident. #ClinicalTrials #CTIS #CTR #EMA #ClinicalResearch #RegulatoryAffairs

1

A current look at the topics of leadership, change, and (a lack of?) diversity in the executive ranks within the CDMO market. I've been working as an executive search consultant in this sector for over four years and have observed an exciting and continuously evolving environment. The CDMO industry is dynamic, fast-paced, and driven by cost and efficiency. While this agility allows for rapid adaptability and is appealing to transformational leaders, it also presents challenges, such as intense competition and pressure on margins, which can strain resources and impact long-term sustainability.

2

📊 State of the Pharma Industry in Germany - 2023 Review 🚀 The latest report from Pharma Deutschland reveals the ongoing strength of the pharmaceutical industry in Germany. Looking back at 2023, the entire healthcare sector contributed 11.5% to the national GDP, with the industrial healthcare sector, driven largely by pharma, contributing €95 billion. Key highlights include: ◼️ Employment Growth: Pharma industry employment surged by 7.4% ◼️ Capital Investments: Despite the end of the COVID-19 vaccine boom, pharmaceutical companies continued to invest billions in new facilities and production capacities in Germany. ◼️ Hotspots for German Pharma based on Emplyment Growth are: Baden-Württemberg, Hessen and Nordrhein-Westfalen For all of us in pharma, especially in the CAPEX world, it’s an exciting time to be part of such a dynamic industry. We’re seeing projects ramping up across Germany and even throughout the wider EU, which means plenty of opportunities ahead for the industry. 🚀💊 As a service provider for PMO and Project Controls, we’re keeping a keen eye on market developments and are excited to see where tomorrow’s projects will take us. 🔍📈 Read the full atricel here: https://lnkd.in/eHHwNkiC #PharmaGermany #HealthcareEconomy #Innovation

45

Supply Chain Resilience: A Must for CDMOs 🎯 In the ever-evolving landscape of the pharmaceutical industry, the importance of supply chain resilience for CDMOs cannot be overstated. Pharmaceutical supply chains are intricate and global, making them susceptible to disruptions. From raw material shortages to geopolitical tensions, the potential for disruption is significant and often unforeseen. As we have seen from the COVID pandemic, CDMOs with robust, flexible supply chain strategies are better positioned to navigate supply chain disruptions. Implementing diversified sourcing strategies, maintaining optimal inventory levels, and leveraging digital technologies are just a few ways to enhance resilience and retain a competitive advantage in an increasingly saturated market. I spend the majority of my time speaking with and networking with supply chain professionals across the life sciences industry - and throughout conversations, the importance of developing robust supply chains and building supply chain resilience remains a consistent hot topic. I'm interested to hear from my wider network - what steps do YOUR business take to build supply chain resilience and maintain robust supply chains? Reach out for a conversation or share your thoughts below! 💬👇 #SupplyChain #CDMO #PharmaceuticalIndustry

11

1 Kommentar